Purine nucleoside phosphorylase (PNP) deficiency has been recently introduced in the newborn screening program in Tuscany. In order to improve the PNP screening efficiency, we developed a 2nd tier test to quantify PNP primary markers deoxyguanosine (dGuo) and deoxyinosine (dIno).
Development and validation of a 2nd tier test for identification of purine nucleoside phosphorylase deficiency patients during expanded newborn screening by liquid chromatography-tandem mass spectrometry / la Marca, G., Giocaliere, E., Malvagia, S., Villanelli, F., Funghini, S., Ombrone, D., Bona, M.D., Forni, G., Canessa, C., Ricci, S., Romano, F., Guerrini, R., Resti, M., Azzari, C.. - In: CLINICAL CHEMISTRY AND LABORATORY MEDICINE. - ISSN 1437-4331. - STAMPA. - 54:(2016), pp. 627-632. [10.1515/cclm-2015-0436]
Development and validation of a 2nd tier test for identification of purine nucleoside phosphorylase deficiency patients during expanded newborn screening by liquid chromatography-tandem mass spectrometry
LA MARCA, GIANCARLO;Ricci, Silvia;GUERRINI, RENZO;AZZARI, CHIARA
2016
Abstract
Purine nucleoside phosphorylase (PNP) deficiency has been recently introduced in the newborn screening program in Tuscany. In order to improve the PNP screening efficiency, we developed a 2nd tier test to quantify PNP primary markers deoxyguanosine (dGuo) and deoxyinosine (dIno).
| File | Dimensione | Formato | |
|---|---|---|---|
|
cclmPNP.pdf
Open Access dal 31/08/2016
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
614.8 kB
Formato
Adobe PDF
|
614.8 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
